Misty Lee, DPM
Foot & Ankle Surgery · Florence, SCNPI 1255503413
Payments from drug & device makers
What this record shows
This record is dominated by other: $12,000 of the $19,007 with a category attached, or 63.1%. Convatec Inc. accounts for 63.4% of it on its own, with 33 other manufacturers making up the rest. 2025 is the largest year on record at $12,355, more than ten times the $916 reported in 2019.
Across 142 payments — averaging $133.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Convatec Inc.$12K
- Peerless Surgical Inc.$2K
- Organogenesis Inc.$1K
- Kerecis Limited$997
- Musculoskeletal Transplant Foundation Inc.$442
- Paratek Pharmaceuticals, Inc.$296
- plus $2K from 28 others
What the payments were for
- Travel & lodging$8434%
- Food & beverage$4,96426%
- Education$1,2006%
- Other$12,00063%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Convatec Inc. | 6 | $12,058 |
| Peerless Surgical Inc. | 9 | $2,045 |
| Organogenesis Inc. | 14 | $1,097 |
| Kerecis Limited | 6 | $997 |
| Musculoskeletal Transplant Foundation Inc. | 7 | $442 |
| Paratek Pharmaceuticals, Inc. | 17 | $296 |
| Amgen(2 entities) | 9 | $227 |
| Treace Medical Concepts, Inc. | 4 | $209 |
| Averitas Pharma Inc. | 8 | $191 |
| AbbVie(2 entities) | 9 | $156 |
| GRT US Holding, Inc. | 6 | $138 |
| Stability Biologics, LLC | 1 | $125 |
| Bioventus LLC | 5 | $110 |
| Melinta Therapeutics, LLC | 5 | $108 |
| Bone Support Inc. | 1 | $101 |
| Boston Scientific | 4 | $94 |
| Smith+Nephew | 4 | $90 |
| Integra Lifesciences Corporation | 3 | $74 |
| Stryker(2 entities) | 4 | $71 |
| Nevro Corp. | 3 | $58 |
| KCI USA, Inc. | 2 | $45 |
| Nabriva Therapeutics, PLC | 2 | $31 |
| Paragon 28, Inc. | 1 | $30 |
| Degen Medical, Inc. | 1 | $29 |
| Zyla Life Sciences, Inc. | 2 | $29 |
| Linvatec Corporation | 1 | $24 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $22 |
| ANI Pharmaceuticals, Inc. | 1 | $19 |
| Globus Medical | 1 | $18 |
| Kuros Biosciences USA, Inc | 1 | $17 |
| Innovation Technologies Inc | 1 | $16 |
| Biotissue Holdings Inc. | 1 | $14 |
| Medline Industries LP | 1 | $12 |
| Cashflow Solutions, LLC | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- InnovaMatrix AC$12,000
- Kerecis Omega3 Marigen$1,949
- Kerecis Omega3 SurgiClose$1,388
- Kerecis Omega3 GraftGuide$916
- PuraPly$341
- Puraply, NuShield, Affinity$320
- Apligraf$127
- KRYSTEXXA$110
- Kerecis Omega3 Wound$110
- Kerecis Omega3 Surgibind$110
- NuShield$108
- Lapiplasty System$103
- CERAMENTBONE VOID FILLER$101
- CERAMENT G$101
- NUZYRA$100
How this compares
$19,007 in reported general payments places this provider in the 75th percentile of 87 foot & ankle surgery providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| QutenzaCapsaicin/Skin Cleanser | 18 | $61,040 |
| Ciclopirox | 43 | $1,556 |
| Linezolid | 15 | $697 |
| Mupirocin | 25 | $388 |
| Celecoxib | 22 | $355 |
| Gabapentin | 37 | $300 |
| CiclopiroxCiclopirox Olamine | 14 | $281 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 58 | $239 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 27 | $236 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 36 | $225 |
| Silver Sulfadiazine | 15 | $221 |
| SsdSilver Sulfadiazine | 15 | $206 |
| Diclofenac Sodium | 17 | $205 |
| Doxycycline Hyclate | 41 | $154 |
| Pregabalin | 18 | $148 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GRT US Holding, Inc.Qutenza | $138 | $61,04018 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 87 foot & ankle surgery providers in South Carolina.
Other foot & ankle surgery in Florence
- Jason OdellFlorence$46K
- Paul WeatherbyFlorence$23K
- Christopher TyreeFlorence$21K
- Jessica FinkFlorence$7K
- Benjamin OverleyHilton Head Island$643K
- Tyler GonzalezColumbia$525K
- Alison GartenRock Hill$419K
- Christopher GrossCharleston$394K
- Robert KleinGreenville$358K
- William JamesColumbia$222K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.